Argenx Se (ARGX) Cost of Revenue (2022 - 2026)
Argenx Se's (ARGX) quarterly Cost of Revenue came in at $145.0 million in Q2 2026, up 30.93% on a YoY basis from $110.7 million in Q2 2025, and up 19.83% quarter-over-quarter from $121.0 million in Q1 2026.
Powered by 
Analysis
Argenx Se (ARGX) Cost of Revenue (2022 - 2026) Analysis & Trends
Argenx Se (ARGX) has reported Cost of Revenue for 5 consecutive years, with $145.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Cost of Revenue rose 30.93% year-over-year to $145.0 million; the trailing twelve-month figure through Jun 2026 stood at $525.1 million (up 62.33% YoY), and the FY2025 full-year result was $450.7 million, up 98.28% from the prior year.
- Cost of Revenue grew to $145.0 million in Q2 2026 per ARGX's latest filing, from $121.0 million in the prior quarter.
- Across five years, Cost of Revenue topped out at $149.7 million in Q4 2025 and bottomed at $1.4 million in Q1 2022.
- Historically, Cost of Revenue has averaged $60.6 million across 5 years, with a median of $47.8 million in 2024.
- The sharpest annual moves came in 2023 and 2026: Cost of Revenue surged 1236.37% in 2023, then jumped 30.93% in 2026.
- Over 5 years, Cost of Revenue stood at $12.8 million in 2022, then jumped by 208.75% to $39.5 million in 2023, then soared by 84.05% to $72.7 million in 2024, then surged by 106.02% to $149.7 million in 2025, then retreated by 3.13% to $145.0 million in 2026.
- According to Business Quant data, Cost of Revenue over the past three periods registered $145.0 million, $121.0 million, and $149.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 8.05 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | 4.29 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | 4.40 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | 3.71 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | 2.52 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 2.81 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | 1.58 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | 4.09 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 489.20 Mn |
| 10 | Argenx Se | 58.53 Bn | 53.35 Bn | 1.37 Bn | 145.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 145.00 Mn |
| Mar 31, 2026 | 121.00 Mn |
| Dec 31, 2025 | 149.69 Mn |
| Sep 30, 2025 | 109.43 Mn |
| Jun 30, 2025 | 110.75 Mn |
| Mar 31, 2025 | 81.00 Mn |
| Dec 31, 2024 | 72.66 Mn |
| Sep 30, 2024 | 59.07 Mn |
| Jun 30, 2024 | 52.38 Mn |
| Mar 31, 2024 | 43.18 Mn |
| Dec 31, 2023 | 39.48 Mn |
| Sep 30, 2023 | 36.00 Mn |
| Jun 30, 2023 | 24.02 Mn |
| Mar 31, 2023 | 18.34 Mn |
| Dec 31, 2022 | 12.79 Mn |
| Sep 30, 2022 | 10.26 Mn |
| Jun 30, 2022 | 5.01 Mn |
| Mar 31, 2022 | 1.37 Mn |
API Access
Argenx Se Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=ARGX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "ARGX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=ARGX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();